Supplement Combination for Healthy Subjects

Recruiting in Palo Alto (17 mi)

Age: 18 - 65

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: University of South Carolina

Trial Summary

What is the purpose of this trial?The purpose of this clinical trial is to assess the effects of a supplement combination on measures of sleep quality and stress in healthy adults.

Eligibility Criteria

This trial is for healthy adults interested in exploring how a combination of supplements might affect their sleep quality and stress levels. Specific eligibility criteria are not provided, so it's best to contact the study organizers for details on who can participate.

Inclusion Criteria

Physically active: participating in resistance and/or endurance exercise ≥150 min/wk for ≥6 mo

I am 18-50 years old with a healthy weight for my height.

Participant will be asked about dietary supplementation use within the past 6 months. If participant began taking a supplement within the past month, participant will be asked to discontinue supplement use followed by a 2-week washout prior to participation. In all other cases, supplement use will be asked to be maintained throughout the study

+2 more

Exclusion Criteria

I am not pregnant, breastfeeding, or planning to become pregnant during the study.

Participants currently taking any investigational products

I am on medication for sleep or to manage cortisol levels.

+4 more

Participant Groups

The trial is testing different combinations of supplements taken in the morning (Ashwagandha, Rhodiola rosea) and evening (Magnesium threonate, L-theanine, apigenin), as well as all combined versus placebo. The goal is to see if these combinations improve sleep and reduce stress.

4Treatment groups

Experimental Treatment

Active Control

Placebo Group

Group I: AM active, PM activeExperimental Treatment1 Intervention

Group II: AM active, PM placeboActive Control1 Intervention

Group III: AM placebo, PM activeActive Control1 Intervention

Group IV: AM placebo, PM placeboPlacebo Group1 Intervention